Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Tg Therapeuticscmn (TGTX)

14.4 -0.3 (-2.04%)

04-20 16:00

Open:

14.7

Pre. Close:

14.7

High:

14.8

Low:

14.35

Volume:

630,587

Market Cap:

1053M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

14.808 - 14.884

14.884 - 14.942

Low:

14.175 - 14.254

14.254 - 14.315

Close:

14.276 - 14.407

14.407 - 14.508

Technical analysis  (as of: 2018-04-20 4:34:06 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 17.62     One year: 19.27

Support:

Support1: 12.80    Support2: 10.65

Resistance:

Resistance1: 15.09    Resistance2: 16.50

Pivot:

13.77

Moving Averages:

MA(5): 14.10     MA(20): 13.97

MA(100): 11.84     MA(250): 11.21

MACD:

MACD(12,26): -0.09     Signal(12,26,9): -0.16

%K %D:

%K(14,3): 77.78     %D(3): 62.41

RSI:

RSI(14): 52.34

52-Week:

High: 17.35  Low: 7.25  Change(%): 38.5

Average Vol(K):

3-Month: 153462  10-Days 101335

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
TGTX has closed below upper band by 19.9%. Bollinger Bands are 20.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-13T09:17:12-04:00
Biotechs, Whipsawed By Volatility, Still Remain Well-Positioned

2018-04-12T10:22:39-04:00
Verastem: A Solid Player On A Crowded Field

2018-04-09T15:35:18-04:00
Q4 Biotech Catalyst Watchlist: Phase 3 Clinical Trials

2018-03-31T09:11:12-04:00
2 Small Biotechs For The Second Quarter

2018-03-29T23:25:40-04:00
TG Therapeutics (TGTX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

2018-03-20T12:01:06-04:00
Biotechs Approaching New Waters

2018-03-09T16:20:49-05:00
Biotech Forum Daily Digest For March 9th

2018-03-08T07:33:01-05:00
TG Therapeutics misses by $0.02, beats on revenue

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

75.58

Shares Float (M)

57.66

% Held by Insiders

25.40

% Held by Institutions

46.10

Shares Short (K)

12433

Shares Short Prior Month (K)

17560

Stock Financials

EPS

-1.910

EPS Est. Current Year

-1.840

EPS Est. Next Year

-1.640

EPS Est. Next Quarter

-0.450

Forward EPS

-1.959

Book Value (p.s.)

15.790

PEG Ratio

Profit Margin

Operating Margin

-77904.57

Return on Assets (ttm)

-155.7

Return on Equity (ttm)

-230.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.159

Qtrly Earnings Growth

Operating Cash Flow (M)

-93.76

Levered Free Cash Flow (M)

-49.77

atoplab.com

Valuation

P/E

-7.54

P/E Growth Ratio

-0.02

P/BV

0.91

P/S

P/CF

-11.61

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-04-30

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.